Supreme Court Reverses Preliminary Injunction Against Government for Coercing Social Media Firms to Censor Speech
The states of Missouri and Louisiana, together with three doctors, a health care advocate and a news website, sued federal officials and agencies including Anthony Fauci, MD, FBI special agents, the U.S. Food and Drug Administration (FDA), Department of Homeland Security (DHS), Department of Health and Human Services (HHS), State Department and Election Assistance Commission. […]
Weight Loss Drugs Ozempic and Wegovy Linked to Vision Loss
Semaglutide, the active ingredient in popular weight loss drugs sold under brand names like Ozempic and Wegovy, has been linked to a condition that causes vision loss, according to a new study published on July 3, 2024 in JAMA Ophthalmology. In the study, patients who were prescribed semaglutide were more likely to develop non-arteritic anterior […]
Supreme Court Rejects Challenges to COVID-19 Shot Mandates
The U.S. Supreme Court has rejected appeals to two COVID shot mandate-related cases brought by Children’s Health Defense (CHD). In one case, CHD appealed a lower court ruling that the non-profit group lacked standing to sue the U.S. Food and Drug Administration (FDA) over its authorization of the COVID-19 shots for young children. In the […]
Pfizer Sued for Misleading Claims About Its COVID Shot
The State of Kansas has sued Pfizer, Inc. over its mRNA (messenger ribonucleic acid) COVID-19 shot, Comirnaty. Kansas attorney general Kris Kobach alleges that the pharmaceutical giant labeled and marketed the novel biologic as, “safe and effective,” while knowing that the product could cause, “serious adverse events,” including myocarditis and pericarditis, failed pregnancies and death.”1 Texas […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]
FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine
On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.’s new pneumococcal conjugate vaccine Capvaxive (formerly V116) for adults 18 years of age and older. The vaccine is designed to protect against 21 types of the bacteria causing pneumococcal disease, which can lead to severe infection in the lungs […]
